Mr. Jake R. Nunn, CFA MBA, is Partner at New Enterprise Associates LLC and a Member at CFA Society of San Francisco.
He is on the Board of Directors at Trevena, Inc and Dermira, Inc.
Prior to joining NEA in 2006, Mr. Nunn was an Independent Director at Transcept Pharmaceuticals, Inc., Trivascular Technologies, Inc., a Principal at MPM BioEquities Adviser LLC, Investment Banker at Alex. Brown & Sons, Inc and a Portfolio Manager at Franklin Resources, Inc.
He also served on the board at Hyperion Therapeutics, Inc., TriVascular, Inc., Aciex Therapeutics, Inc and Trivascular2, Inc.
Mr. Nunn received his AB in Economics from Dartmouth College and an MBA from the Stanford Graduate School of Business. Mr. Nunn holds the Chartered Financial Analyst designation and is a member of the CFA Society of San Francisco.